{
    "Trade/Device Name(s)": [
        "Diazyme Direct HbA1c Assay (Enzymatic, On-Board Lysis)",
        "Diazyme Direct HbA1c Assay Calibrator Set",
        "Diazyme Direct HbA1c Assay Control Set"
    ],
    "Submitter Information": "Diazyme Laboratories",
    "510(k) Number": "K160762",
    "Predicate Device Reference 510(k) Number(s)": [
        "K070734"
    ],
    "Regulatory Class": "Class II, Class I",
    "Product Code(s)": [
        "LCP",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "October 5, 2016",
    "Summary Letter Received Date": "October 6, 2016",
    "Submission Date": "November 15, 2016",
    "Regulation Number(s)": [
        "21 CFR 864.7470",
        "21 CFR 862.1150",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glycosylated hemoglobin assay",
        "Calibrator",
        "Quality control material"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "hematology"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c (HbA1c)"
    ],
    "Specimen Type(s)": [
        "Venous whole blood",
        "K2 EDTA Human whole blood"
    ],
    "Specimen Container(s)": [
        "K2 EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Roche Modular P automated chemistry analyzer",
        "Hitachi 917"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic assay",
        "On-board blood lysis",
        "Protease digestion",
        "Fructosyl valine oxidase reaction",
        "Horseradish peroxidase (POD) colorimetric detection"
    ],
    "Methodologies": [
        "Quantitative enzymatic assay",
        "Chromogenic detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reagent",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Diazyme Direct HbA1c Assay (Enzymatic, On-Board Lysis), calibrator and control sets for quantitative determination and monitoring of HbA1c in whole blood using automated chemistry analyzers",
    "Indications for Use Summary": "Intended for quantitative determination of stable HbA1c in venous whole blood samples with on-board blood lysis; not for diagnosis or screening for diabetes, used for monitoring long-term glucose control in persons with diabetes in clinical laboratories",
    "fda_folder": "Hematology"
}